Bioxyne Limited (ASX:BXN)

Market Cap	123.20M +71.8%
Revenue (ttm)	47.95M +178.2%
Net Income	8.97M +300.8%
EPS	0.00 +259.9%
Shares Out	2.24B
PE Ratio	13.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,582,219
Average Volume	4,347,405
Open	0.0560
Previous Close	0.0560
Day's Range	0.0540 - 0.0570
52-Week Range	0.0200 - 0.0620
Beta	0.69
RSI	55.98
Earnings Date	Feb 25, 2026

About Bioxyne

Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Online, and Retail) of Consumer Health and Novel Food Products; and Wholesale of Patented Probiotics segments. The company offers active pharmaceutical ingr...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1998
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BXN